VANDA PHARMACEUTICALS INC. Accounts Payable
VANDA PHARMACEUTICALS INC. (VNDA) had Accounts Payable of $1.63 million as of 2015-06-30, per its 10-Q filed 2015-07-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2015-07-31
- 2015-06-30: Accounts Payable, Current $1.63M.
- 2015-03-31: Accounts Payable, Current $1.49M.
- 2014-12-31: Accounts Payable, Current $835.00K.
- 2014-09-30: Accounts Payable, Current $547.00K.
| Period end | Accounts Payable, Current |
|---|---|
| 2015-06-30 | $1.63M 10-Q · filed 2015-07-31 |
| 2015-03-31 | $1.49M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $835.00K 10-Q · filed 2015-07-31 |
| 2014-09-30 | $547.00K 10-Q · filed 2014-10-27 |
| 2014-06-30 | $248.00K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $953.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $661.00K 10-K · filed 2015-03-13 |
| 2013-09-30 | $369.00K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $1.17M 10-Q · filed 2013-07-31 |
| 2013-03-31 | $1.11M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $287.00K 10-K · filed 2014-02-25 |
| 2012-09-30 | $1.09M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $1.69M 10-Q · filed 2012-08-03 |
| 2012-03-31 | $780.00K 10-Q · filed 2012-05-09 |
| 2011-12-31 | $996.00K 10-K · filed 2013-02-26 |
| 2011-09-30 | $1.33M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $1.34M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $648.00K 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |